addit
recent
studi
examin
clinic
applic
stem
cell
cell
therapi
product
regen
medicin
highlight
import
secur
hesc
clinic
grade
qualiti
hovatta
tannenbaum
et
al
thu
sever
group
attempt
establish
hesc
line
remov
animalderiv
compon
cultur
condit
maintain
xenofre
condit
report
establish
new
hesc
line
success
cultur
xenofre
cultur
condit
publish
et
al
crook
et
al
ilic
et
al
tannenbaum
et
al
mani
effort
made
develop
appropri
stem
cell
cultur
protocol
use
hesc
clinic
applic
establish
cultur
freez
thaw
skottman
et
al
sinc
first
establish
hesc
thomson
et
al
hesc
cultur
condit
use
mous
deriv
fibroblast
mous
embryon
fibroblast
mef
sto
feeder
cell
howev
concern
remain
regard
potenti
risk
cell
line
contamin
unknown
compon
secret
anim
deriv
materi
therefor
studi
perform
overcom
challeng
soong
et
al
exampl
studi
examin
replac
mous
deriv
fibroblast
human
tissuederiv
feeder
cell
human
foreskin
fibroblast
fetal
muscl
fibroblast
richard
et
al
umbil
cord
deriv
mesenchym
stem
cell
ding
et
al
marrow
stromal
cell
havasi
et
al
placent
cell
park
et
al
addit
research
also
attempt
develop
extracellular
matrix
xenofre
medium
use
feederfre
condit
cultur
without
feeder
cell
also
continu
effort
maintain
hesc
effici
stabli
establish
new
cell
line
develop
cultur
condit
human
amniot
fluid
cell
hafc
use
prenat
genet
diagnosi
examin
possibl
fetal
abnorm
cell
easili
obtain
pregnant
women
second
midtrimest
amniocentesi
prusa
hengstschlag
although
studi
character
variou
type
cell
found
amniot
fluid
cell
amniot
fluid
shown
capabl
differenti
three
germ
layer
cell
thu
cell
potenti
applic
materi
studi
neuron
differenti
stem
cell
prusa
hengstschlag
kook
et
al
amniot
fluid
deriv
stem
cell
intermedi
characterist
hesc
adult
stem
cell
express
marker
express
bone
marrow
deriv
mesenchym
stem
cell
cell
also
express
marker
undifferenti
state
he
cell
includ
nanog
bajek
et
al
particular
repres
marker
undifferenti
hesc
shown
express
amniot
fluidderiv
stem
cell
prusa
et
al
moreov
hafc
shown
higher
reprogram
effici
establish
induc
pluripot
stem
cell
ipsc
somat
cell
galend
et
al
addit
studi
use
hafc
feeder
cell
kim
et
al
success
cultur
hesc
use
hafc
feeder
cell
instead
mous
deriv
fibroblast
commonli
use
report
also
describ
mainten
undifferenti
state
hesc
use
human
amniot
fluid
cellderiv
stem
cell
feeder
cell
without
addit
basic
fibroblast
growth
factor
bfgf
et
al
new
hesc
line
establish
use
amniot
fluidderiv
mesenchym
stem
cell
feeder
cell
soong
et
al
current
studi
examin
whether
clinic
grade
hesc
could
cultur
xenofre
medium
without
anim
deriv
materi
cultur
condit
use
human
extracellular
matrix
hafc
feeder
cell
hesc
line
use
present
studi
fetal
bovin
serum
fb
hyclon
use
incub
co
day
inactiv
hafc
cell
growth
suppress
treatment
mitomycin
c
sigma
h
cell
transfer
cellstartco
cultur
dish
densiti
cellscm
order
examin
whether
hesc
cultur
use
amniot
fluid
cell
feeder
cell
maintain
properti
immunocytochemistri
icc
revers
transcript
polymeras
chain
reaction
rtpcr
flow
cytometri
use
analyz
expressionact
alkalin
phosphatas
ap
cell
surfac
marker
undifferenti
state
hesc
express
pluripot
marker
ie
day
subcultur
wash
dpb
invitrogen
fix
paraformaldehyd
pfa
usb
ap
express
examin
stain
use
alkalin
phosphatas
diagnost
kit
sigma
accord
manufactur
instruct
immunocytochemistri
icc
pluripot
tabl
centrifug
optim
volum
dpb
ad
cell
pellet
resuspend
cell
subject
analysi
use
flow
cytomet
facsaria
bd
bioscienc
acid
nonhuman
sialic
acid
hesc
cultur
use
hafc
feeder
cell
without
anim
deriv
compon
flow
cytomet
use
determin
whether
biolegend
anim
deriv
compon
could
detect
sampl
prepar
describ
flow
cytometri
analysi
marker
undifferenti
cell
incub
primari
antibodi
target
follow
incub
antichicken
millipor
secondari
antibodi
cell
analyz
use
flow
cytomet
facscalibur
bd
scienc
cultur
passag
maintain
undifferenti
state
use
hafc
feeder
cell
passag
cultur
hesc
maintain
properti
hafc
use
feeder
cell
fibroblast
type
shown
fig
cultur
use
establish
human
foreskin
fibroblast
establish
mef
adapt
well
hafc
without
complic
round
singl
layer
typic
hesc
coloni
observ
fig
c
studi
attempt
replac
materi
gener
use
hesc
cultur
human
materi
order
minim
exposur
hesc
anim
deriv
compon
cultur
thu
hafc
character
cultur
hafc
test
passag
ap
activ
determin
use
ap
stain
kit
data
indic
undifferenti
state
maintain
fig
addit
immunocytochemistri
detect
two
experiment
group
posit
respons
fig
flow
cytometri
analysi
use
specif
antibodi
order
examin
whether
anim
deriv
materi
present
use
describ
cell
cultur
condit
result
show
grown
hafc
contamin
fig
contrast
detect
cultur
sto
fig
current
use
research
protocol
medium
contain
mous
deriv
fibroblast
fb
gener
richard
et
al
kim
et
al
park
et
al
ding
et
al
havasi
et
al
soong
et
al
et
al
clinic
grade
hesc
line
establish
cultur
xenofre
environ
ilic
et
al
tannenbaum
et
al
studi
popular
product
commerci
widespread
use
villadiaz
et
al
present
studi
aim
determin
whether
stacey
et
al
sever
factor
test
human
deriv
materi
cell
use
biolog
medicin
cobo
et
al
recent
studi
hpsc
includ
hesc
focus
next
stage
clinic
applic
necessit
compat
cell
therapi
product
clinic
applic
final
goal
stem
cell
studi
therefor
addit
chang
effici
cultur
condit
must
establish
growth
hesc
reduc
anim
deriv
compon
replac
human
human
deriv
materi
basic
cell
cultur
environ
studi
also
conduct
xenofre
feederfre
environ
cultur
without
feeder
cell
addit
improv
cultur
condit
qualiti
manag
cultur
hesc
standard
procedur
includ
detect
microorgan
virus
anim
deriv
materi
identif
inappropri
harm
substanc
need
develop
standard
product
clinic
grade
hesc
next
preparatori
step
applic
hesc
cell
base
therapi
regen
medicin
